Natural compound screening predicts novel GSK-3 isoform-specific inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Natural compound screening predicts novel GSK-3 isoform-specific inhibitors

Published:2024-10 Issue: Volume:225 Page:68-80
ISSN:0300-9084
Container-title:Biochimie
language:en
Short-container-title:Biochimie

Author:

Ahmad Firdos^ORCID,Gupta Anamika,Marzook Hezlin,Woodgett James R.,Saleh Mohamed A.,Qaisar Rizwan

Funder

University of Sharjah

Publisher

Elsevier BV

Reference66 articles.

1. The GSK-3 family as therapeutic target for myocardial diseases;Lal;Circ. Res.,2015

2. Chronic neuregulin-1 beta treatment mitigates the progression of postmyocardial infarction heart failure in the setting of type 1 diabetes mellitus by suppressing myocardial apoptosis, fibrosis, and key oxidant-producing enzymes;Gupte;J. Card. Fail.,2017

3. Cardiomyocyte-GSK-3beta deficiency induces cardiac progenitor cell proliferation in the ischemic heart through paracrine mechanisms;Yusuf;J. Cell. Physiol.,2022

4. Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development;Force;J. Biol. Chem.,2009

5. GSK-3 at the heart of cardiometabolic diseases: isoform-specific targeting is critical to therapeutic benefit;Umbarkar;Biochim. Biophys. Acta, Mol. Basis Dis.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP